102 related articles for article (PubMed ID: 10096174)
21. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
Alkuwari E; Auger M
Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
[TBL] [Abstract][Full Text] [Related]
22. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
23. Axillary Dissection with Access Minimized (ADAM): a new technique for lymph node dissection in conservative surgery for breast cancer.
Paepke S; Schwarz-Boeger U; Kiechle M; Jacobs VR
Int J Fertil Womens Med; 2003; 48(5):232-7. PubMed ID: 14626380
[TBL] [Abstract][Full Text] [Related]
24. [Mastoscopic axillary lymph node dissection for the patients with breast cancer].
Luo CY; Zhang J; Lin H; Yang Q; Huang X; Xue L; Zhang YZ; Li GH
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1946-8. PubMed ID: 14703427
[TBL] [Abstract][Full Text] [Related]
25. Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer.
Ahlgren J; Holmberg L; Bergh J; Liljegren G
Eur J Surg Oncol; 2002 Mar; 28(2):97-102. PubMed ID: 11884042
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
27. Variability in axillary lymph node dissection for breast cancer.
Schaapveld M; Otter R; de Vries EG; Fidler V; Grond JA; van der Graaf WT; de Vogel PL; Willemse PH
J Surg Oncol; 2004 Jul; 87(1):4-12. PubMed ID: 15221913
[TBL] [Abstract][Full Text] [Related]
28. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
29. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
Samphao S; Eremin JM; El-Sheemy M; Eremin O
Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
[TBL] [Abstract][Full Text] [Related]
30. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count.
Bélanger J; Soucy G; Sidéris L; Leblanc G; Drolet P; Mitchell A; Leclerc YE; Beaudet J; Dufresne MP; Dubé P
J Am Coll Surg; 2008 Apr; 206(4):704-8. PubMed ID: 18387477
[TBL] [Abstract][Full Text] [Related]
32. [Sentinel lymph node biopsy in breast cancer: value for predicting the status of axillary node].
Su F; Jia W; Li H; Zeng Y; Chen J
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):784-6. PubMed ID: 11832165
[TBL] [Abstract][Full Text] [Related]
33. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
34. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
[TBL] [Abstract][Full Text] [Related]
35. Impact of axillary level I and II lymphnode dissection on the therapy of stage I and II breast cancer.
Tocchi A; Mazzoni G; Bettelli E; Miccini M; Giuliani A; Cassini D
Panminerva Med; 2001 Jun; 43(2):103-7. PubMed ID: 11449180
[TBL] [Abstract][Full Text] [Related]
36. Video-assisted axillary surgery for cancer: non-randomized comparison with conventional techniques.
Hussein O; El-Nahhas W; El-Saed A; Denewer A
Breast; 2007 Oct; 16(5):513-9. PubMed ID: 17532217
[TBL] [Abstract][Full Text] [Related]
37. [-Breast neoplasms: axillary lymph node excision--at what price-].
Rageth JC
Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
[No Abstract] [Full Text] [Related]
38. Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph.
Montalto E; Mangraviti S; Costa G; Carrega P; Morandi B; Pezzino G; Bonaccorsi I; Cancellieri A; Mingari MC; Mesiti M; Ferlazzo G; Melioli G
Immunol Lett; 2010 Jun; 131(1):67-72. PubMed ID: 20298720
[TBL] [Abstract][Full Text] [Related]
39. Lanreotide Autogel 90 mg and lymphorrhea prevention after axillary node dissection in breast cancer: a phase III double blind, randomized, placebo-controlled trial.
Gauthier T; Garuchet-Bigot A; Marin B; Mollard J; Loum O; Fermeaux V; Jammet I; Kanoun D; Maubon A; Aubard Y
Eur J Surg Oncol; 2012 Oct; 38(10):902-9. PubMed ID: 22703757
[TBL] [Abstract][Full Text] [Related]
40. [Meta-analysis of endoscopic axillary lymph node dissection versus conventional open excision for breast cancer].
Ding B; Qian L; Zhao Y; Wu W; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):782-9. PubMed ID: 26267692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]